These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2829546)

  • 1. Characterization of JHMV variants isolated from rat brain and cultured neural cells after wild type JHMV infection.
    Taguchi F; Siddell S; Wege H; Massa P; ter Meulen V
    Adv Exp Med Biol; 1987; 218():343-9. PubMed ID: 2829546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV.
    Taguchi F; Massa PT; ter Meulen V
    Virology; 1986 Nov; 155(1):267-70. PubMed ID: 3776101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM.
    Taguchi F; Siddell SG; Wege H; ter Meulen V
    J Virol; 1985 May; 54(2):429-35. PubMed ID: 2985806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus.
    Sorensen O; Saravani A; Dales S
    Microb Pathog; 1987 Feb; 2(2):79-90. PubMed ID: 2853273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV.
    Taguchi F; Kubo H; Takahashi H; Suzuki H
    Virology; 1995 Apr; 208(1):67-74. PubMed ID: 11831732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovirulence of six different murine coronavirus JHMV variants for rats.
    Matsubara Y; Watanabe R; Taguchi F
    Virus Res; 1991 Jun; 20(1):45-58. PubMed ID: 1656623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.
    Sorensen O; Dugre R; Percy D; Dales S
    Infect Immun; 1982 Sep; 37(3):1248-60. PubMed ID: 6290393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro models of demyelinating disease, XXIII: Infection by JHM virus of athymic rats.
    Sorensen O; Saravani A; Dales S
    Adv Exp Med Biol; 1987; 218():383-90. PubMed ID: 2829549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection and characterization of multiple hemagglutinin-esterase (HE)-defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus.
    Yokomori K; Stohlman SA; Lai MM
    Virology; 1993 Jan; 192(1):170-8. PubMed ID: 8390751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.
    Morris VL; Tieszer C; Mackinnon J; Percy D
    Virology; 1989 Mar; 169(1):127-36. PubMed ID: 2538027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.
    Fleming JO; Trousdale MD; Bradbury J; Stohlman SA; Weiner LP
    Microb Pathog; 1987 Jul; 3(1):9-20. PubMed ID: 2848172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro models of demyelinating disease. XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS.
    Beushausen S; Dales S
    Virology; 1985 Feb; 141(1):89-101. PubMed ID: 2983498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of the basal ganglia by a murine coronavirus.
    Fishman PS; Gass JS; Swoveland PT; Lavi E; Highkin MK; Weiss SR
    Science; 1985 Aug; 229(4716):877-9. PubMed ID: 2992088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein.
    Taguchi F; Fleming JO
    Virology; 1989 Mar; 169(1):233-5. PubMed ID: 2538034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-independent spread of a highly neurotropic murine coronavirus JHMV strain from initially infected microglial cells in mixed neural cultures.
    Nakagaki K; Nakagaki K; Taguchi F
    J Virol; 2005 May; 79(10):6102-10. PubMed ID: 15857995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.
    Dalziel RG; Lampert PW; Talbot PJ; Buchmeier MJ
    J Virol; 1986 Aug; 59(2):463-71. PubMed ID: 3016306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.
    Wilson GA; Dales S
    J Virol; 1988 Sep; 62(9):3371-7. PubMed ID: 2841490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system.
    Fazakerley JK; Parker SE; Bloom F; Buchmeier MJ
    Virology; 1992 Mar; 187(1):178-88. PubMed ID: 1310555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-independent infection of murine coronavirus: analysis by spinoculation.
    Watanabe R; Matsuyama S; Taguchi F
    J Virol; 2006 May; 80(10):4901-8. PubMed ID: 16641281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
    Wege H; Winter J; Massa P; Dörries R; ter Meulen V
    Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.